Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06750471 · ClinicalTrials.gov registry record · Phase 4
Dupixent Study for Alternate Administration
A Phase 4 study of Chronic Disease and Sinusitis, sponsored by Madigan Army Medical Center.
- Active
- Registry status
- Phase 4
- Development phase
- 30
- Enrollment target
- 1
- Study location
NCT06750471 is a Phase 4 study of Chronic Disease and Sinusitis that is active but no longer recruiting, run by Madigan Army Medical Center. The registered enrollment target is 30 participants, below the 89,943-participant average among 48 other Chronic Disease trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state.
The verdict
NCT06750471, a Phase 4 study of Chronic Disease and Sinusitis, is active but no longer recruiting, sponsored by Madigan Army Medical Center.
- ACTIVE NOT RECRUITING
- Registry status
- Phase 4
- Development phase
- 30 participants
- Enrollment target
- 1
- Study location
Study Summary
Investigators will investigate an alternate Dupilumab administration schedule in patients with recurrent chronic rhinosinusitis with nasal polyposis, who have a history of full endoscopic sinus surgery and are on appropriate topical medical therapies. Specifically, investigators will investigate if the alternate schedule of drug administration is non-inferior in both subjective and objective outcomes.
Conditions Studied
Interventions
- BIOLOGICAL Dupilumab
Study Locations (1)
Washington
- Madigan Army Medical Center - Tacoma
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2021-10-14 |
| Est. Completion | 2025-12 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06750471
The ClinicalTrials.gov registry entry for NCT06750471 describes a study currently listed as active not recruiting, categorized as Phase 4. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 89,943-participant average among 48 other Chronic Disease trials with a reported enrollment target (100% lower). The listed sponsor is Madigan Army Medical Center, which has 22 total studies on file at ClinicalTrials.gov.
The record links to 3 conditions, with Chronic Disease appearing as the primary indexed condition, and to 1 intervention - of which Dupilumab is the first listed.
NCT06750471 reports 1 study location spanning 1 distinct geographic area - top geographies include Washington.
Frequently Asked Questions
What is clinical trial NCT06750471 about?
NCT06750471 is a clinical study titled "Dupixent Study for Alternate Administration". Investigators will investigate an alternate Dupilumab administration schedule in patients with recurrent chronic rhinosinusitis with nasal polyposis, who have a history of full endoscopic sinus surgery and are on appropriate topical medical therapies. Specifically, investigators will investigate if ...
What is the current status of trial NCT06750471?
This trial is currently active not recruiting. It is a Phase 4 study. The enrollment target is 30 participants. The study started on 2021-10-14. Estimated completion is 2025-12.
What conditions does trial NCT06750471 study?
This clinical trial studies the following conditions: Chronic Disease, Sinusitis, Nasal Polyps.
What interventions are being tested in trial NCT06750471?
The interventions under investigation include: Dupilumab (BIOLOGICAL).
Who is sponsoring clinical trial NCT06750471?
This trial is sponsored by Madigan Army Medical Center, which has 22 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06750471 being conducted?
This trial has 1 study location across Washington. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Chronic Disease
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Click & Pick Study
RECRUITING · NA
-
Evaluation of AI Cost Prediction Model to Enroll Patients in Complex Care Management Program
RECRUITING · NA
-
RIVER At Home Ketamine Protocols
RECRUITING
-
Effects of Personalized Exercise Prescriptions Through Mobile Health on Physical Activity and Health Outcomes in the Cancer Survivors
RECRUITING · NA
-
Comparative Effectiveness of IIMR Versus CDSMP
RECRUITING · NA
-
Training Community Members to be Coaches to Deliver the HealthyLifetime Program
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.